2898 — Sunho Biologics Balance Sheet
0.000.00%
Last trade - 00:00HealthcareSmall Cap
- HK$968.20m
- HK$1.38bn
Annual balance sheet for Sunho Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | PROSPECTUS |
| Standards: | IFRS | IFRS |
| Status: | Final | Final |
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 1.82 | 210 |
| Net Total Receivables | 1 | 0.999 |
| Total Inventory | ||
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 14.6 | 227 |
| Gross Property, Plant And Equipment | ||
| Accumulated Depreciation | ||
| Net Property, Plant And Equipment | 46.2 | 50.8 |
| Net Intangible Assets | ||
| Other Long Term Assets | ||
| Total Assets | 70.9 | 290 |
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Current Portion of Long Term Debt / Capital Leases | ||
| Total Other Current Liabilities | ||
| Total Current Liabilities | 66.2 | 388 |
| Long Term Debt | ||
| Capital Lease Obligations | ||
| Total Long Term Debt | ||
| Total Debt | ||
| Total Liabilities | 72.4 | 395 |
| Common Stock | ||
| Retained Earnings (Accumulated Deficit) | ||
| Treasury Stock | ||
| Total Equity | -1.5 | -104 |
| Total Liabilities & Shareholders' Equity | 70.9 | 290 |
| Total Common Shares Outstanding |